2022 Annual Report
March 30, 2023
Annual Report for the year ended 31 December 2022.
The 2022 Annual Report outlines BioCurate progressing the portfolio through key stage gates and growing the pipeline of early-stage projects through an expansion of the Proof of Concept Scheme (POC). A successful fourth round of BioCurate Opportunity Applications (BOA) was completed as well as the generation of novel projects by the BioCurate team. This builds on the strong foundations and positive momentum gained over the previous years towards BioCurate’s mission to commercialise potential therapeutic candidates and create impact on the lives of patients.